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The use of three different monoclonal antibodies specific for
human venlrkular myosin heavy chains in 1hr vlscaliveion of the
location and extent of necrosis in slogs with experimental acute
myocardial infarction and In hunts is described, Using n classic
immunohittorhrmkat method ., ex vivo aculysis of heart slices In
dogs with acute myocardial Infarction susjected to Intravenous
injection of unlabeled antimyosin antibodies or anifmyosin anti
hedies labeled with indium-Ill, it was observed that all antibody
fragments specifically reached the targeted necrotic zone <2 h
after antibody injection and remained bound for up to 24 h . In a
limited but significant number of cases (S of the 12 humans and 11
of
43 dogs), it was possible to image the necrotic one in vivo as
The loss of membrane integrity of injured cardiac myocytes
in myocardial infarction aid cardiac disease induces intra-
cellular enzyme leakage . release of contractile proteins and
abnormalities in the electrical and mechanical variables of
the heart. These metabolic disturbances can be measured by
different invasive or noninvasive physical or biologic me,h-
ods such as titration of some myocardial components in the
blood, direct or indirect visualization of ischemic or necrotic
zones, or both, imaging analysis a different injected sab-
stanees and biophysical analysis of cardiac activities by
electrocardiography. angiography and wall motion . All of
these methods are complementary, quite rapidly applicable
and of general and long-term use . The final objective is thus
to determine the location and extent of the necrosis or
cardiac defect. This is cmcia~ is assessing the further risk for
damaged myocardium and adapting therapeutic procedures.
As early as 1976, Khaw ct al . (1-8) began applying
mdiolabeled antimyosin antibodies for the in vise detection
of myocardial cell death . The antibodies selectively enter the
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early as 2 to 4 h after antibody injection . In other cases, Individual
blond clearance variations retarded or even prevented in vivo
necrosis detedioc . Higher antimyosin fixation values were ob-
tained in the necrotic zones In daps with a rapid blood clearance
rclative to that
of
the ether dogs,
It is concluded unit antimyosin antibodies always reached
necrotic areas within 2 h . If blond clearance was rapid, in vivo
imaging of the necrotic area was possible 2 to 6 h after necrosis,
even in humans . In some cases, however, uncontrolled individual
variations in the timing required for sufficient blood clearance
hampered this rapid in vivo detection of myocardial necrosis .
(J Am CoU Cordial 1991 ;18o473-4)
irr^_versibly damaged myocytes and specifically bind to
insoluble mvnsin . In a series of reports, this research group
(1-8) successively described the use of polyclonal antibodies
or subfragments coupled with iodine-131 or indium-I 11, as
well as the use of one monoclonal antibody specific for the
hump+n myosin heavy chains (called RI IDIO) and labeled
with indium. I 11 . They demonstrated that injected antibodies
allow detection and quantification of the necrotic area in
dogs with experimental acute myocardial infarction . In 1986
(9). they successfully injected zntimyosiet antibody labeled
with technetium-99 in patients with acute myocardial infarc-
tion . The must recent imaging reports (10-13) made with
commercially available Fab fragments of this antimyosin
antibody radiolabeled with indium-11I indicated that a pos-
hive scan of the necrotic area can he observed in >90% of
patients if planar or tomographic imaging is performed 27 t
95 after antibody injection .
Comparisons with other traditional techniques for imag-
ing; myocardial necrosis have conclusively shown the reli-
ability of antimyosin imaging and its safety for clinical use in
patients. Antimyosin imaging also makes it possible to
differentiate between necrotic and ischemic areas (14) and is
helpful in identifying cardiac rejection in heterotopie heart
transplants (15-19) and in identifying patients with chronic
idiopathic dilated cardiomyopathy or suspected myocarditis
(20) . A few other laboratories (21,22) have used antimyosin
antibodies for imaging myocardial necrosis, confirming byPhzrmu+e . Avenue Ch, Flahzult . 341160 Montpellier sodas 1 .F ce*
0755-1097/9613,50
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histochemical analysis that the antibody can he specifically
fixed within the infarci area . Curiously, in the most recent
documented study 122) using several different iodine-123-
labeled antimyosin antibodies with relatively high affinities,
no clear differentiation between infarcted and noninfarcled
myocardium was obtained after in vivo imaging .
In the course of our investigation on human cardiac
myosin isoforms (23-26) . we isolated many different mono-
clonal antibodies specific for ventricular and atria) myosin
heavy and light chains. Because of their were high affinities
for ventricular myosin heavy chains . some of these antibod-
ies have been selected for antimyosin imaging experiments
in dogs with acute myocardial infarction . The present inves-
tigation was undertaken to assess whether such antimyosin
antibodies could reach necrotic areas, determine how long
this would take and tentatively define the decisive factors for
rapid in vivo imaging . The antibodies were injected into dogs
with experimental acute myocardial infarction and into hu-
mans after acute myocardial infarction .
Methods
Antimyosin antibodies. Monoclonal antibodies were pre-
pared from mice immunized with myosin prepared from the
hypertrophic left ventricle of a 53 year old woman with
obstructive cardiomyopathy. The procedures used for
arouse immunization, fusion, screening, cloning, production
and purification of antibodies have been previously de-
scribed. (23 24) . Three different monoclonal antibodies were
selected for the present study because of their high affinity
for the beta-myosin heavy chains, of which >95% are
expressed within the human and dog ventricles (24) . These
three antibodies, the epimpes of which were located on the
myosin heavy chain subfragment 2
(24),
are further desig .
noted as F26
.4F4 (IgGl), F36.5G12 (IgG2a) aid F26,2DIi
(Ig(13) . The affinities of the three antibodies for human or
canine beta-myosin heavy chains in solution ranged between
2 and 5
x
10 - ' a M -I . Note that the three antibodies were of
different immunoglobulin subtypes.
Other antibodies or injected substances . Two other mono-
clonal antibody fragments, one raised against the carcino-
embryonic antigen (CEA) and another against the carbohydrate
19.9 antigen, were injected in control experiments
either in an unlabeled form or coupled with indium-111, as
were the antimyosin antibody fragments
. indium- I I I chlo-
ride or indium-Ill coupled with dicthylenetriamine pen-
taacetic acid anhydride (DTPA) were also injected as control
substances .
Preparation and activity control of antibody fragments.
To produce antibody fragments, concentrated antibody so-
lutions (5 to 7 mg/ml) purified through protein-A sepharose
columns from ascitic liquids were predialyzed overnight
against 10 mM sodium formiate buffer, pH 2 .8 (27), then
dialyzed overnight against 50 mM sodium acetate buffer, pH
4 .2 for IgGI and 1gG3 and pH 3 .8 for IgG2a. Pepsin was
added at a 1% enzyme to substrate ratio (weight/weight) to
tACC Vd . it. No. 2
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obtain IgGI
Flab'),
fragments, at a 2
.5% ratio to obtain
IgG2a Flab'), fragments and at a 3% ratio to obtain IgG3
F(ab')2 fragments . The reaction was stopped by adjustment
to pH 8 .0 with Tris 2 M. 7 he F(ab') 2 and Fe fragments were
separated from undigested antibodies by chromatography on
ultragel ACA 44 columns (IBF) equilibrate) in 10 mM of
sodium phosphate 0.15 M of sodium chloride buffer, pH 7 .4 .
The Flab'1
2
fragments were separated from Fc fragments by
protein-A affinity chromatography (27,28) . The Fab' frag.
ments were obtained through controlled reduction of the
Rub'), fragments, using beta-mercapteethanol for 2 .5 h in a
0 .5M phosphate buffer containing 50 mM of ethylenediami
.
netermacetic acid (EDTA), pH 6.0 . It was purified using ton
HR200 gel filtration, eluted with 0.1 M of phosphate buffer
containing 5 MM of EDTA, pH 6 .0. The sulfhydryl groups
were blocked with iodoacetamide, the excess of which was
removed by diafiltration in sodium chloride. 0.15 M. The
antibody solution was finally concentrated to S to 10 mg/ml .
All operations were performed in sterile and apyrogenic
conditions .
To radiolabel the antibody fragments with indium-Ilf,
these fragments were covalently linked with DTPA by the
cyclic anhydride method (29). An aliquot of a 0 .5 to I mg
DTPA fragment was then mixed with indium-l I I at doses
ranging from 1 .4 to 4 mCi and incubated at room temperature
for 10 to 15 min. Thin layer chromatography was performed
to measure indium-III binding . The numbers of DTPA per
antibody fragment molecule obtained varied from one to
four . At least 95% incorporation was achieved after purifi-
cation on Sephadex G t® . Radiolabeled antibody was stored
at -20°C and injection was performed within 24 h after
immunoreactivity control . Radioimmunoassay was per-
formed using a direct binding assay in microplate wells
coated with 2 .5 )ug of cardiac myosin . Radiolabeled antibody
( 10, 5 and 2 .5 mg) was added and incubated overnight . Plates
were washed and counted normally (25). Immunoreactivity,
levels ranged between 42% and 68% . Nonspecific binding
was about 1%.
Electrophoresis was carried out in 2% to 16% and 4% to
30% SDS polyacrylamide gels to control the size of the
different F(ab')2 and Fab' fragments. Their immunoreactiv-
ity was checked by direct ELISA assays or, solid- ;base
coated antigen (I to 2 pg/well) (human ventricular myosin
was used for the antimyosin fragments) . The antigen.
antibody complexes were labeled by an antimouse immunu-
globulin or anti .F(ab')2 antibody conjugated with alkaline
phosphatase . Before each experiment, immunoreactivity of
the labeled antibody fragment was compared with that of the
unlabeled fragment coupled with DTPA . No significant
variations were observed between the immunotitration
curves or both fragments .
Experimental Studies in Dogs
Induction of myocardial infarction . Myocardial infarction
was induced in 75 adult beagle dogs weighing 8 to 16 kg .
JACC Vol. It . No. 2
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Table 1 . Subgroups of 82 Dogs With or Without Myocaidial
Infarction Receiving an Injection of Either Unlabeled or
Radiolabeled Antimynsin or Other Antibodies
AMI ® acute myocardial mtarcta-n .
Seven additional sham-operated dogs were used as Control
dogs (Table
I) .
The procedure for inducing experimental
infarction has been previously described (30 .31) . In brief.
after anesthetizing the dogs with intravenous ketamine
(8 mg/kg body weight) . a radiopaque catheter (7F) was
inserted into the left carotid artery, guided by fluoroscopy
and advanced to the root of the a
orta
. i t
was then advanced
into the main left coronary artery and the anterior descend-
ing or circumflex coronary artery . The thrombogenic device
was a copper wire (outer diameter 0.25 mm) formed into a
coil around a 0.5 mm diameter needle; the overall length of
the coil varied between 2
.5 and 3
.5 mm
. The coil was placed
3 to 4 mm from the end of the catheter and pushed out by a
plunger, whereupon it floated freely through the lumen of the
selected vessel. The distal position in the heart was initially
verified by video monitoring . The first arrhythmic episodes
appeared 2 to 6 h later, indicating onset of experimental
myocardial infarction . The dogs did not undergo throm-
bolytic therapy .
Seven dogs underaenr a sham operulion . They were
processed in the same manner as the 75 other dogs, but no
copper wire was introduced . Absence of acute myocardial
infarction was confirmed by clinical and electrical examina-
tions.
Experimental procedure (Table
1).
Unlabeled or labeled
antimyosin fragments (diluted in approximately 10 ml vol-
ume of physiologic buffer) or other substances were slowly
injected intravenously, in most cases 18 to 20 h after coil
positioning . In a very few cases. antibody fragments were
injected a few hours or several days after coil positioning
(Table 2)
. The total radioactivity injected with indium- I 1I-
labeled antimyosin fragments varied between too and 4 mCi
and was equal to 2 mCi for the injected indium-1 I t-labeled
control antibodies . Tube I summarizes the different groups
of dogs with or without myocardial infarction injected with
either unlabeled or radiolabeled antimyosin fragments or
other antibody or substances. Dog hearts injected with
radioactive and nonradioactive substances were processed
differently .
Antimynsin scintigraphy . Each dog was immobilized with
intraperitoneal 4% chloral hydrate (0.01 mug body weight)
LI GER ET AL .
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and then placed in a prone position beneath the detector .
Scintigraphic images were obtained at 5 min, 30 min . I h and
then every hear op to 10 and 24 h after injection of the
labeled protein- using a Phillips camera equipped with a
medium energy collimator . For each image, the counts were
sampled for 5 min
. At the last measurement, they were
sampled for 10 min . The anesthetized dogs were imaged in
anteroposlerior and, if necessary, 45' left anterior oblique
and left lateral positions.
ImmunohistoChemtstry. The dogs that underwent injec-
tion of nonradioactive antibodies or substances were killed
by pentobarbital overdose at various times after injection .
The excised heart was cut rrnnsversely and then frozen in
isupentane chilled in ligeid nitrogen . Complete cross sec-
tions of the frozen ventricles were cut on a cryostat at
0,7 mm and fixed with cold acetone . The presence of
antimyosin antibodies bound to the myocardial tissue was
determined by their reaction with biotinylated specific anti.
mouse (Fab' I immonoglohulin fragments . The immune com-
plexes "cue detected by streptavidin-biotinylated peroxi-
dase-preformed complexes and stained by AEC (3 amino 9
ethyl carbazole) and hematoxylin (32) . No histochemical
determinations of the necrotic areas were carried out after
this immunohistocoemical analysis .
Pnstimaging ex vivo analyses and determination of necrotic
areas. After the imaging session consecutive to the injection
of indium-Ill-labeled antibodies or other substances . the
dogs were killed by pentobarbital overdose and the heart
was excised . The whole heart was imaged and then five or
six heart slices cut parallel to the atrioventricular groove
were imaged . The slices were stained on incubation for
15 min at 37"C in a solution of 1% rriphenyltetrazolium
chloride in phosphate buffer, 0 .1 M pH 7 .4
. They were then
immersed in a 10% formalin solution and rinsed with distilled
water The injured myocardium appeared as a yellow area,
being depleted of dehydrogenase, whereas normal myocar-
dium was stained dark red . Each slice was photographed and
the images were projected onto paper where the epicardial
and eadocardial Contours were traced . Myocardial areas
were excised and weighed . Necrotic areas delineated by
triphenyltetrazolium chloride staining were also traced on
paper . excised and weighed. The thickness of each slice was
measured and the necrotic volume calculated and evaluated
in grams . The entire infarct zone of each slice was then cut
into small cubes, weighed and sampled to determine the
relative radioactivity by gamma scintillation counting . Some
samples from normal myocardial zones were token for
comparative purposes.
Tissues samplesfram the liver, spleen,
lungs, kidneys and
skelernl muscle were also excised, weighed and counted .
Blood samples were collected in heparin tubes at l . 15, 30
and 45 min and at I, 2, 4, 6 and 24 h after antibody injection .
After centrifugation, the radioactivity of 0 .5 ml of superna-
tant was determined by gamma scintillation counting . Clear-
ance rate was calcualted as the percent decrease from blood
activity I min after antibody injection .
Do
gs
Dog,
WahAMI With. ., AMI
Unlubolcd antibody
Antimynsin
I:
Others If I
Indium-III antibody
Antimynsin 43 4
CM hors 10 I
Tole1 75 7
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Clinical Sfadies in Humans
Patient selection . Twelve patients (seven men and five
women) wilt, a fist ante myocardial infarction were in-
cluded in this study. They were admitted within 3 h
after the
onset of chest pain . The l2 patients were between 55 and 89
years of age (mean 71). One 62 year old patient with unstable
chest pain, who was designated as a normal subject . was also
included . Acute myocardial infarction was diagnosed ac-
cording to electrocardiographic criteria (the appearance of
abnormalQ waves accompanied by an elevated
ST segment
and subsequent inversion of theT wave). The diagnosis was
retroactively confirmed
by significant increases in either
creatine kinase ICK) . CKMB
isoenzyme (E .C . [Enzyme
Commission] No. 2.7 .3 .2) or lactate dehydrogenase
(LDH)
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(E .C . 1 .1 .1 .27) activity. The onset of infarction was rou-
tinely determined by a combination of clinical, electrical ant
enzymatic observations. Thrombolytic (streptokinase) ther-
apy was administered in all patients within 4 t after the onset
of chest pain . Reperfusion was successful
:a all, as later
detected by coronary artery examination . All patients gave
informed consent for antimyosin injection according to cri-
teria of the Institutional Ethics Committee. Antirnyosin
scintigraphy was performed in the poslacute phase between
4 and 8 days after onset of acute myocardial infarction .
Animyosin sctnflgraphy. The antibody (Fab' or Flab'1 ;)
fragments used in humans were prepared Gora oscines of
P36 .5GIt (IgG2a) or F26 .4F4 (IgGll and labeled with in-
dium-111 under sterile and pyrogen-free conditions, To test
for hypers?nsilivity, 0.05 ml of radioactive antimyosin was
administered inteadermally. Indium-I I ]-labeled antimyosin
fragments ware intravenously administered . If no wheal or
flare was eb'.erved within 15 min, 0.5 ml of antimyosin
fragments labeled with 2 mCi of indium-Ill was intrave-
nously administered . Scintigraphic images were obtained
between 4 and 6 it after injection of the labeled protein, using
a Phillips camera equipped with a medium energy collimator
.
For each image, the counts were sampled for 5 min . In a few
cases, scintigraphic images were also obtained 24 h after
antibody injection . In these cases, the counts were sampled
for 10 min. Patients were imaged in anteroposterior and, in
some cases, 45
° left anterior oblique and left lateral posi-
tions .
Procedure. All planar sciutigraphic . histochemical and
immunocytochemical images were inspected visually to de-
termine if there was antimyosin uptake in the myocardium .
Visual analysis to assess the presence or absence of antimy-
osin or other substances in the myocardium was done by
consensus among three observers. No visual score was
required to discriminate between uptake and nonuptake . The
experimental variability in the dogs was clearly higher than
the occasional inter- and intraobserver variability. Quantita
five msasurements were only possible when indium-III
substances were injected .
Statistical analysis. All data are expressed as mean t slues
^- SD. Carrelations were analyzed by linear regression
computed by the least squares method . Differences between
groups of dogs were compared using the two sample paired
or unpaired Student's t test . Statistical differences were
considered significant at p •c 0.65.
Results-
Experimental Myocardial !r(farcrion in Dogs
Location and -steal of necrosis (Tables I and 2) . The
present study was designed to determine the best experimen-
tat conditions to obtain successful rid rapid antimyosin
uptake into necrotic area, in dogs with acute myocardial
infarction . Table I describes the different groups of dogs
with or without myocardial infarction given an injection of
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either unlabeled or radiolaheled antimyosin fragments or
other substances, The induced myocardial infarct ranged
from 0.5 to 7 e . The necrotic areas were located in various
parts of the heart as determined by the location of the
experimentally introduced copper wire . For the 75 dogs with
myocardial infarction, they were distributed as follows:
apical or anteroapical (45%) . anterior (23%) . anterior in
association with a right ventricular location (13%), inferior
(13%), septal (3%) and basal (3%) . The location and extent of
the necrosis in the 43 dogs injected with indium-I I I-labeled
antibody fragment are summarized in Table 2,
Immunucytochemkat localisation of experimental myocar .
dial infarction . An immunohistochemical approach was first
used to characterize the best experimental conditions for the
fixation of injected unlabeled antimyosin F(ab') r
fragments
in the myocardial tissue
. Figure I presents a typical
experi-
ment in which highly intense labeling with the arttimouse
immunaglabulins was observed in the necrotic area in one
dog with acute myocardial lntarction and injected with a
F(ab')_ fragment specific for the ventricular myosin heavy
chains 16 h after coil positioning. The most intense antibody
uptake was observed on the border of the necrotic areas near
vessels (Fig . IA . arrow). No actual uptake was observed in
viable myocardial areas in the same dog (Fig . III) or in
another sham-operated dog (not shown) . No labeling was
observed in necrosed or necrosis-free myocardial areas in
ooe dog with acute myocardial infarction injected with a
F(ab'),
fragment from an anticarcino-embryonic antigen
(CEA) nonspecific for any myocardial component (Fig
. I, C
and D)
. These results confirm that injected antimyosin
fragments specifically reached myosin through leaking mem-
branes of dead ventricular cells (1-10J .
Tire relative intensity of antimyosin fixation in the nec-
rosed Ns . necrosisfree, areas was visually determined from
the relative hismimmunolngic staining of the bound antibody
and was found
to
vary with the amount of antibody injected
(Fig. 2A)
. With low dotes of injected antibody (such as
12 µg/kg body weight), uptake was almost exclusively ob-
served on the borders of necrotic myocytes . With higher
amounts of injected aotibady, uptake was deeper within the
dead cells . The labeling intensities of necrotic areas . ob-
tained with all of the three antibody fragments injected here .
were comparable . suggesting that uptake was independent of
the antibody subtype (Fig. 2R). Finally, equal labeling inten-
sity of necrotic areas was observed from 2 to 24 h after
antibody injection (Fig . 2C1 . No immuoolabeling was de-
tecled in the myocardial areas without necrosis under all
injection conditions (antimyosin subtype or quantity, analy-
sis period). The same immunohistdlogic experiments made
with fragments prepared from antibodies nonspecific far
myocardial tissue showed completely negative uptake in
living or dead myocardial cells in dogs with or without acute
myocardial infarction . From the results of these preliminary
experiments, we decided to inject approximately .'i0 tog of
antibody fragmenttkg body weight .
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-b-In vivo antimyosin imaging in dogs with acute myocardial subtypes were coupled with indium-1I I by means of the
infarction (Tables I to 3) . The Fab' or Flab'), fragments bi0mctional chelating agent diethylenetriamine pentaacetic
prepared from the three antimyosin antibodies of different acid anhydride (DTPA). Other antibodies or substances
A . Antibody dose
ME
12 50
B- Antibody subtype
IgG 1 IgG2a
C. Time after antibody injection
2
Necrosed
I
6
Normal
B
300 (pig/ Kit)
IgG3
24
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Figure 1 . Binding of Flai ),
fragments to two Jog% with
acute myocardial infarction . IgG binding, which w
immunohislochemically detected with antimouse alka .
line phosphatase-coupled antibodies. was observed in
the necrotic IA) but not normal zone IB, of myocardium
in the dog injected with the antimyosin antibody (upper-
panel).
No binding was observed in the heart of the other
dog (lower panel) injected with an anticarcino-
embryonic antigen IC and D, respectivetyl. The white
arrow denotes a oecros:d zone.
Figure 2 . Binding of antimyosin Flah't i
fragments in nine different dogs with acute
myocardial infarction, which was tmmu •
nohistochemically detected with anti .
in- a'ka noe phosphatase-coupled anti-
bodies. binding variations watt observed
carding to the dose of antihody injected
(row A), the antibody subtype (row B) and
th- time of detection after antibody injec-
tion (row C) . The while arrows denote the
necrosed zones .
(ACC Vol, 19, No 2
Aug- 1991 :473' M4
Table 3
.
Control Dogs
10
-
IUI N'itt 51 ocardtzl In ruction Olsen an Inieclion of Radiulabeled
(- rnup B (blood clearance
time 21o
24 ht
AI
71
511
arollp C bland dc'arenct
mime > 24 hl
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nonspecific for myocardial tissue were, also labeled with
indium-III
. Labeled antimyosin antibodies were miected
into 43 dogs with and 4 without acute myocardial infarction .
in most cases 14 to 16 h after the onset or myocardial
infarction (Tables I and 2). Other nonspecific labeled sub-
stances were injected into 10 dogs with and
I dog wilhom
acute myocardial infarction (Tables I and 31, All of these
dogs
were examined by scintigraphy . using a gamma camera
on the entire anesthetized animal for 34 h afrr antibody
injection . The heart was then examined ex vivo . The dif-
ferent variables that were measured ex eivo in each dog
hean, such us the extent and location of the necrosis- the
radioactivity incorporated in the necrotic and normal myo-
cardium and the corresponding uptake ratio- which w
:n
defined as the ratio of both radioactivity values- are summa-
need in Tables 2 and 3 .
In the 43 dogs with acute myocardial infarction recessing
an injection of indiom •I I I antimyosin fragments, we ob
served high between-dog variations in the time required to
obtain enough blood clearance to image :mtimcosin uptake
in the necrotic areas . We arbitrarily classified the 43 dogs
into three groups according to the time required for
.i .ihly
removal of the circulating
radioactivity.
Eleven of the 43
dogs with ;!cute myocardial infarction about I in
a'
had
rapid blood clearance of circulating radioactivity from ? Io
6 h after antimyosin injection Ifuahcr elesigna :ed as group
A). As a result of intense tint s holy' uptake, all or these dogs
showed clearly positive scan,, strictly limited to the necrotic
areas (Table 2A, Fig . -',Al . Twenty-sit of the 43 dogs had
relatively slaw blond clearance .
occurring
from 6 to 24 h
after antimyosin injection
further
designated us group B).
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Only 20 of the group B dogs had a positive scan (Table 2 .
Fig, 38) . Unexpectedly, it was impossible to detect the
necrotic areas by in vivo immunoscintigraphy in six dogs
from group B despite the fact that their blood was free of any
circulating radioactivity . Finally
. 6 of the 43 dogs still had
circulating radioactivity in their blood 24 h after antimyosin
injection (further designated as group C) . The necrotic area
was undelcetable in vivo, probably because of
the absence
of contrast maletial as a result of remaining circulating
radioactivity (Table 2C . Fig
.
30 .
FAr (ivrr Jogs u'i1Jro :(r aellre myocardial lnfarrlian in-
jected with radiolabeled antimyosin Iragmonls had relatively
taptd blood clearance within the same lime range as the
group A and B dogs (Fig . 3151)- The 10 other "control" dogs
wish and I without acute myocardial infarction injected with
a radiolahelcd F(aV), fragment of the anticarcino •e mbryonic
antigen or the anticarbohydrtc 19 .9 antigen labeled with
indium-I I I
. or with Indiana- I I I chloride or DTPA indium-
ill, were also examined ty sclntigraphy . Differences in
blood deaanec times were then observed between dogs
(Table 31. The heart from 9 of the ID dogs was free of
roJioactieity -24 h after injection . No positive scans were
obtained in necrotic area, -
Teri of the I I group A dogs and 8 dogs in group B had
fecal myocardial infarcrion
. All group C dogs had patchy or
diffuse necrotic myocardial areas . In a few dogs. because of
( :pad blood clearance . the infarct zone was detectable as
sarty as 2 h after antibody injection
. Hepatic or renal uptake
of antimyosin usually did trot interfere with antibody uptake
identification, The in vivo measured ratios of the necrotic
and normal myocardium in the 43 dogs ranged from 3 to 8.
Antib,dics or Nanspeanc %I ocaruial Sub,tzncd
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to' cpmlg
xadea:wln dy per x
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with a mean value of 5
.,
3
. We tried to determine whether
different experimeldal variables used in the preparation of
mdiolatteled antimyosin antibodies could explain the differ-
ences observed in blood clearance
. The respective influ-
ences of the antibody subfragments (Flab']_ or Fab'). their
eubtypes. the number of chelated DTPA and the specific
63
2 DTPA/A6
q4 DTPA/A6
TIME SOR BLOOD CLEARANCE (S)
'"It „
0 u vin/,
0 .1 pcuyc
radioactivity of indium were thus tested. None of these
variables proved clearly detenlliaatn for obtaining rapid
blood clearance, which was crucial for detecting antibody
uptake in necrotic areas (Fig . 41- We also observed that 6 of
the 43 dogs with myocardial infarction injected with labeled
antimyosin either < or >18 to Zith after coil positio"ing(Doq
IACC Vol . 19 . No. E
Aug., I95I 471-u1
(2
l1re 3. Blond clearance and antimyosin uptake . Scin-
igniphie in vivo imaging at different times after indium .
lit diethylenetriamine pentaacetic acid anhydride
antimyosin Rats'), fragment injection (time ITI
6 =
5 min ; TI = 2 h ; T, = 20 h) in three dogs with acute
myocardial
infarction trees A
.
Band Cl and one normal
dog (roe NI. Arrows indicate hypcrfixation in the nee-
rosed myocardial areas after the bland was cleared of
circulating radioactivity, Rddioacnvity in the lower re-
gion of the scirlligmm represents liver uptake .
Fig- 4
. Disltibulion of the 43 degs with acute nyo-
cardial infarction injected with indium-1 i 1 diethylene-
triamine pentaacetic acid anhydride (DTPA) animyo-
sin fragments, according to their blood clearance time
)either 2 1
. 6
. 6 to 24 or 524 h after the antibody
injection)
The
distributions were similar for all exper.
men ta l vmiabls (antibody subtype, number of DTPA
bound per antibody (Ab) and dose of specific radioac-
tivity per pg of antibody molecule) .
'Slausucally different trim 1alue, ih,ened In the (use other dop pinups •
	
puvme . peesnve.
36 in group 2A . Dog 47 in group 22 B I and
Dog`
38, 45, 46 and
48 in group 282 in Table 21 were found in different blood
clearance groups . The delay berwcen the antibody injection
and onset of myocardial infarction did not stem to influence
the blood clearance rate .
Blend clearance of indium-l i f antibody fragments . Blood
clearance variables were in the same range for all dogs
studied irrespective of differences in experimental condi-
tions. Blood radioactivity was maximal about I min after
intravenous injection . This value was arbitrarily set at i(((Ye
of circulating radioactivity . Circulating radioactivity de-
creased exponentially to basal values at -24 h : this wa, also
the case for F(ab'), or Fab' fragments . The time course was
consistent with an initial rapid extravascular clearance .
followed by two slower elearanc °s. These decreases are
represented by three time IT1 c nt_ms T, - 7 = 4 . min T;
= 1 .2 ' J.4, h and T, - I I x 4 u . The same value, (saryhlg
from about Y/ to Imo% of the radioactivity observed after
I min injection) were observed for the residual blood activity
after 24 h in the three dug groups . Thus . the antimyosin
blood pool had a half-life of I to 2 h in all groups
. Injection
of free indium-I11 chloride in one dog without acute myo-
cardial infarction was followed by a very delayed blood
clearance 1>24 hl
: this outcome contrasted with the 4 h
blond clearance time ; observed in two dog, with acute
myocardial infarction given an injection of DTPA coupled
indium-111 (Dogs 52 and 63 in Table 31 .
Postimaging ex vivo analyses . The excised hear) was
washed free of any circulating blood and analyzed with a
gamma camera (described in A4ethodsl- The heart in all 43
dogs with acute myocardial infarction given an inlection of
radiolabeled antimyosin fragments had a positive ex vivo
scan hyperfocused in the necrotic areas . I he in vivo location
coincided with That observed in anatomic heart section, .
Detection of this positive immunofixation was independent
of the antibody subtype . the antiludy subfragmcnt . the
specific radioactivity, the time delay between infarct onset
and antibody injection and even the location of necrosis
.
Biodistributions of indium-I I I were determined within the
normal and necrosed myocardium (Tables 2 and 3) and
within liver, kidney and skeletal muscles (Table 4) . The
value, for the necrotic Lone determined by triphenyltetra-
znlium chloride staining and ex viva measurements of incor-
porated radioactivity in 43 dogs (Table 2_) were poorly
correlated (r = 8_611
. Table 4 summarizes the different mean
values in relation to specific blood clearance kinetics
ob-
tained
in the 43 dogs with myocardial infarctiun given an
injection of indium-I I I DTPA antimyosin fragments . Each
variable set was independently compared using r multitest
analysis among the four groups of Gigs . In fact . only the
mean value observed for the radioactivity incorporated
within the necrotic myocardium in group 82 dogs (that is .
those with rapid blood clearance but with undetectable
necrosis in vivo) differed significantly from any mean value
observed in the other three groups of dogs . A value of t
2 .34 (p 0.021 was observed when the radioactivity uptake
levels in the necrotic myocardium in group B2 were com-
pared with values in the other three groups . The differences
i the uptake ratios. which are usually considered an index
of specificity of the anribody injected or the efficiency of the
procedure . or both . actually resulted from the differences
observed in the radioactivity uptake in the necrotic myocar-
dium . Other variables- such as the radioactivity values for
the liver . kidneys and necrosis free skeletal muscle. did not
differ among the different groups
of
dogs (Table 4). No
experimental variable clearly accounted for differences in
the radioactivity incorporated within the necrotic area ob-
served between group B2 and the other groups of dogs . The
relatively low radioactivity values associated with a large
necrosis I Dogs 37 and 88 in group 82) or higher radioactivity
values associated with a very small necrosis (Dogs 45 and 46
in group ii?) could explain why such necroses were unde-
( ected in vivo .
Considering the ex vivo radioactivity measurements in
the control dog group IT able 3) . we observed that there was
always significantly more radioactivity incorporated into the
necrosed area than into the normal myocardium ; conse-
quently. the uptake ratios ranged from 2 .1 to 3 .5 (mean 2 .51 .
The mean values of incorporated radioactivity were 71 - 20
and 29 u x 10' cpm/g . respectively and were significantly
different. with a t value of 8 .6 (p < 11.00) . This difference was
the consequence of an increased permeability due to the
1ACC Vnl. 18, No 2
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Table 4 . BiaduviribIII- of Indium-I I I-DI PA-,5nlimyo,in Fragment, aI 24 h After Imravenous Injection in 43 Dogs With
Myocardia : Infarction
LmeAe in Ill°
rpmrg Organ
Group A,, III
tro ut, St It
y1}
JY
Group H2 In -61 GroutCIn=61
lime ale, lnJnerlon hi
Ills hmd4 61024 :•24
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Lot,
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n
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A
C
6h
6h
24h
D
6h
24h
24h
membrane defect resulting fmm the necrosis. but was indepen-
dent of the nature of the injected labeled substance . However,
both mean values of incorporated radioactivity were in the
same range as those in normal myocardium in the 43 dogs
receiving an injection of labeled antimyosin antibodies.
In Vivo Antitnyosin Imaging in Humans
Five of the 12 patients with acute myocardial infarction
had rapid blood clearance within 6 h after antibody injection
(as in group A dogs) . Five patients with acute myocardial
infarction had blood clearance at 24 h (as in group B dogs)
.
Two patients had no blood clearance even at 24 h (as in
group C dogs) . The "normal" subject (with unstable angina)
had rapid blood clearance within 6 h after antimyosin injec-
tion. Necrosis was clearly visible in 10 patients (as in groups
A and B) as soon as blood clearance was complete, thus
allowing the scintigraphic contrast (Fig . 5). The necrotic
tACC Vd . IN, No . 2
Aueml IWI
:a7J-u4
Figure 5 . Scintigraphtc in vivo imaging of five patients (A .
B. C . D and F) with recent myocardial infarction injected
with indium-111 diethylenetriamine pentaacetic acid anhy-
dride antimyosin F(ab')i fragments (4 ;AXIti ) . Scinfgams
were made 6 h IA . B. CI or 24 h (D . E, Fl after antibody
itjection . Scintigram E is the 24 h image of the same patient
observed at 6 h in scintigram C. Arrows indicate hypemx-
ation in the necrosed myocardial areas . The activity in the
lower area of the images is due to liver activity . Patient A
had an apically located infarction, Patients B, C and D had
an anteroseptat infarction. Patient F had no blood clearance
24 h after antibody injection .
zones were located at different places (apical in two patients
.
inferior in three, inferolateral in one and anteroscpial in four
and were either focal (in six patients) or patchy (in four
patients) . There was no significant correlation with antibody
subtypes, subfragmeuts used or location of the necrosis .'t'he
in vivo measured ratio between the necrotic and normal
myocardium was 1.5 x 0 .1 . The necrotic heartlung ratio was
2 .5 ± 0.5 .
Discussion
Antimyosln antibody fixation in myocardial infarcts. The
present results confirm the feasibility of in vivo imaging of
myocardial infarcts by the injection of radiolabeled antimy-
osin antibodies (5-22) . Our experimental study using high
affinity antimyosin antibodies was designed to specifically
test some hypothet;cally crucial experimental variables for
obtaining images of necrotic areas <6 h after antibody
1ACC Vial. Id . Nn . 2
August 19m~473-r4
injection. Hiaologic approaches using either an enzyme .
linked antimoase antibody as a marker of unlabeled lied
antimyosin or fixed radiolaheled antimyosin demonstrate
that injected antimyosin always specifically binds to the
necrotic area . These specific fixations of antimyosin anli-
body fragments were probably obtained within 2 h after
injection in all dogs (lane C, Fig . 2) . Such antibody fixation
was recently shown 00) in postmcrrem histopathologic
analysis of myocardial necrosis in a patient who died of
myocardial rupture some hours after antimyosin injection
.
The rapidity and efficiency of the antibody liaatiun have also
been observed (3) alter intracoronary administration of
myosin-specific antibody fragments, which led to early and
specific 30 min imaging of myocardial infarcts 131 . The
specificity of antimyosin fixation within the necrotic zone
was demonstrated by the low residual antimyosin fixation in
the normal myocardium and the lack of fixation of antibodies
that were nonspecific to the cardiac myosin heavy chains .
The low values observed for the radioactivity within the
skeletal muscles, must of which contained high amounts of
slow/ventricular myosin heavy chains . also revealed that
antibody fixation in infarcted myocardial zones was a con-
sequence of membrane leakage . Antimyosin fixation within
the infarcted myocardium and in patients with myocarditis
(19,20) or cardiac rejection after heart transplantation (16-
19) is actually a sign of myocyte necrosis . As already
documented in the pioneering work of Khaw et al . (I-9) . Ire
antibody subtype, fragmentation, labeling or injectionn con-
ditions apparently do not modify the antibody fixation pro-
cess specifically within the necrotic myocardial areas. Anti-
body fixation occurs independently of the focal or patchy
aspect of the. necrosis and its Vocation . The present results
(Table 2) also confirm that antibody fixation is independent
of the time lag between antibody injection and Onset of
myocardial infarction .
Time periods for visualization of myocardial necrosis . Our
observations demonstrate that by using antimyosin frag-
ments, it is possible to image necrotic zones in dogs with
acute myocardial infarction as early as 2 to 4 h after antibody
injection . We obtained this promising conclusion with re-
sults from a limited but significant number of cases : 5 of 12
humans and I I (group AI of 43 dogs . Indeed, the necrosis
was detectable 4 to 6 h after antibody injection in 10 of 12
patients having rapid blood clearance . These tune periods
for in vivo visualization of necrosis are significantly
shorter
than most of those reported previousy 111
.12) . In a study by
Khaw et al . (9) that included 30 patients having acute
myocardial infarction and given RiIDIO Fab antimyosin
antibody injection, discrete myocard : il antimyosin Incaiizs-
tion was detected as early as 7 h afte' intravenous mJcctlon
in only a few patients. In their repoi1 (91 as well as in the
most documented procedure (10-14) . I or 2 days is usually
required after injection for blood clef rance of the commer-
cially available RI IDIO antimyosin antibody . before the
necrosis can be imaged . Zooming aid sophisticated elec-
tronic procedures for background co~Tecline ace now often
LEGER ET AL .
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used
. This leads to more rapid and reliable in vivo estimates
of infarct size through more precise delineation of the
necrotic areas (5,111 . The difference between our observa-
tions showing a relatively poor correlation (r- 0 .611 he-
tween the in vivo and ex vivo measured infarct sizes and
those recently obtained fir
-
0951 by Johnson et al
. (Ill is
probably due to the lack of any image treatment is Our case .
Nevertheless . using dontreated images, we detected necrotic
areas in vivo within I day in 85% to 941% of the cases at
positive score rates similar to those recently reported 1121 in
humans using RI ID10 antimyosin antibody. Johnson et al .
(11) also showed that coronary reperfusion reduced the
Infarct size . but did not modify the conditions of the anti .
nody fixation or blood clearance conditions, thin . validating
our comparative study in dogs without reperfusion and one
group of humans after reperlusion.
Limitations . These highly encouraging conctasions are
still limited by (air persistent inability to control the crucial
experimental variables required far obtaining more rapid
blood clearance . We do nut currently understand why the
same antimyosin antibodies and experimental conditions
sometimes give rise to negative imaging results with higher
persistent circulating radioactivity . thus preventing in vivo
detection of the necrosis 19,201 The conditions used for
preparing and injecting the antibodies were apparently sim-
ilar if not identical (Fig . 4). The locations and the extent of
the necrotic areas, which differed from one case to another,
could not explain the abnormalities in hematologic or chem-
ical values obtained in some dogs and humans . The only
clear-cut observed biologic difference in these two extreme
blond clearance timing situations concerned the antimyosin
uptake ratio between necrotic and normal myocardium . In
an unexplained way, necrotic tissues in cogs with rapid
blood clearance fixed higher amounts of antimyosin than
these tissues in ether dug, (fable 3). Although the removal
of the constant fragment Fc induces a more rapid blood
clearance by lowering the background
(9) . no differences in
the blood clearance conditions were obtained with either
Fab or Flab')2 antibody fragments (Fig
. 4) . The use of
antimyosin antibodies with one- to twofold higher affinities
compared with those of the RIIDIO antibody could not
explain these earlier imaging contrasts because the same
antibody fragments gave rise to slaver blood clearance in
many other cases . Hoberg et al . (22) . injecting 10 different
iodine- 123-laheted antimyosin fragments of apparently high
affinity, were unable to differentiate in vivo the infarct zone
from the blood pool activity of the heart . Therefore . antimy-
osin affinity i, riot the most sensitive determinant forobtam-
ing rapid imaging . Our unique observation showing that free
indium-( i I circulates persistently after its injection suggests
that differences observed in the blood clearance times could
ha',e resulted from uncontrolled individual differences in the
stability of the injected indium-III antibody complexes .
These differences could also be related to the hypothetical
variations in indium-1 I I quality and its specific radioactivity .
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Clinical Implications . Our unexplained individual varia-
tions in blood clearance
times,
crucial
fur in vivo detection
of the necrosis, are probably the most limiting factor for
extensive development of clinical autimyosin imaging, flora
attention must now be paid to understanding mechanisms
involved in the catabolism of antibody fragments corn plexed
with 17TPA or indium, or both . and possible individual
interference . Recombinant technology will probably help to
make smaller andmyosin antibodies for better polemical
cmaboiic control (33,34) . Ike possible manufacture of anti-
human antibodies and elimination of the constant immuno-
globulin regions will decrease the present anaphylactic risk
when injecting antimouse antibody fragments. Finally, the
direct synthesis of hooks or logs, together with the recom-
binant antibody fragments ., will facilitate the design of
more
stable labeled antibody complexes to he used fur imaging.
Such awaited progress in antibody technology, if it can
accelerate blood clearance in a controlled way . will allow
wide use of amimyosin imaging in cardiology .
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